Thread: Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Ni
View Single Post
Old 01-03-2020, 01:58 PM
MuonOne's Avatar
MuonOne MuonOne is offline
Grand Magnate
  
Join Date: Feb 2007
Posts: 3,269
15 yr Member
MuonOne MuonOne is offline
Grand Magnate
MuonOne's Avatar
 
Join Date: Feb 2007
Posts: 3,269
15 yr Member
Exclamation Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Ni
Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C
Orphazyme reports positive arimoclomol data from open-label phase 2/3 extension in Niemann-Pick disease Type C

Orphazyme continues to have hope for efficacy of arimoclomol in Amyotrophic Lateral Sclerosis . . . :
MuonOne is offline   Reply With QuoteReply With Quote